Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 2,923 | 5,614 | 2,583 | 3,339 | 0 |
| Gross Profit | 2,930 | 5,614 | 2,583 | 3,339 | N/A |
| Operating Expenses | 13,770 | 10,505 | 8,892 | 16,775 | 0 |
| Operating Income | -10,847 | -4,891 | -6,310 | -13,436 | N/A |
| Interest Expense | 90 | 100 | 129 | 110 | 0 |
| Other Income | 3,407 | 3,450 | 2,922 | 128 | 0 |
| Pre-tax Income | -7,530 | -1,540 | -3,517 | -13,418 | 0 |
| Net Income Continuous | -7,519 | -1,540 | -3,517 | -13,418 | N/A |
| Net Income | $-7,519 | $-1,540 | $-3,517 | $-13,418 | $N/A |
| EPS Basic Total Ops | -1.12 | -0.21 | -0.56 | -3.85 | N/A |
| EPS Basic Continuous Ops | -1.10 | -0.23 | -0.54 | -3.82 | N/A |
| EPS Diluted Total Ops | -1.12 | -0.21 | -0.56 | -3.85 | N/A |
| EPS Diluted Continuous Ops | -1.10 | -0.23 | -0.54 | -3.82 | N/A |
| EBITDA(a) | $10,759 | $-4,188 | $-5,710 | $-12,883 | $N/A |